Longenesis’ cover photo
Longenesis

Longenesis

Software Development

Enabling use of health data for research without borders

About us

Longenesis is a digital health startup that contributes to 21st century healthcare by accelerating development of new and better treatments, improving patient engagement and health outcomes. Partnering with leading healthcare institutions, global life sciences companies and national governments Longenesis has empowered more than 700 000 patients across the EU and MENA regions. Longenesis offers digital tools for patient cohort discovery, patient engagement and consent management for life science companies and healthcare institutions Our mission is to build digital bridges between life-science companies, healthcare providers and patients to maximize value creation from health data in a patient-centric and ethical way. For more information visit https://longenesis.com/

Website
https://www.longenesis.com
Industry
Software Development
Company size
11-50 employees
Headquarters
Riga
Type
Partnership
Founded
2018
Specialties
Software, healthcare, Digital Health, and Research

Locations

Employees at Longenesis

Updates

  • Longenesis.Engage now sends reminders automatically, keeping participants on track without extra manual follow-up from your team. 🔷 Less time chasing incomplete activities, more time for patient care. 🔷 Every participant stays engaged in their journey, right from the start. More time for the work that matters. Let's connect and see how Engage can support your care and research programmes. #DigitalHealth #PatientEngagement #Healthtech #ClinicalResearch

    • No alternative text description for this image
  • View organization page for Longenesis

    2,874 followers

    We've expanded Engage's qualified authorisation and signature support to four countries: Estonia, Lithuania, Portugal, and Latvia. 🌍 SmartID, MobileID, Estonian ID card, Chave Móvel Digital (CMD), and eParaksts are all supported, making authentication seamless for patients and removing paper-based consent workflows for care teams. Every signature meets eIDAS qualified electronic signature requirements. 🔐 Verified identity. Streamlined onboarding. Compliant by design. We're continuing to expand across Europe – which country should we add to this list next? 👇 #Longenesis #DigitalHealth #PatientEngagement #eIDAS #Healthtech

    • No alternative text description for this image
  • Digital health tools only work if they're genuinely accessible – to everyone who walks through your door. Engage now supports QR code access for patients who can't log in. When a patient arrives and is unable to authenticate digitally, a care team member can generate a unique, time-limited QR code on the spot. The patient completes their activities without needing an account – and their responses are automatically linked to their profile. No data is lost. No steps are skipped. No one is left out. This matters in practice: older patients, people with lower digital confidence, or anyone who simply doesn't have their credentials to hand. Inclusive design isn't a feature – it's a responsibility. 🔷 Time-limited QR code generated in seconds 🔷 Responses linked directly to the patient's data profile 🔷 No manual data transfer needed for care teams We build Engage so that the technology adapts to the patient – not the other way around. #Longenesis #DigitalHealth #PatientEngagement #Healthtech #Engage

    • No alternative text description for this image
  • Excited to announce our partnership with Datamed! Together, we will provide our women's health awareness and oncology screening toolkit to thousands of Latvians daily, extending the reach to the National level! Kudos to the team, and looking forward to scaling preventative culture together!

    View organization page for Datamed

    667 followers

    We have just joined forces with digital health startup Longenesis to help women across Latvia take a more proactive approach to their health. 🤝 Longenesis has developed skrinings.lv – a dedicated women's health resource designed to raise awareness, foster a culture of preventative care, and encourage women to initiate vital health dialogues with their doctors.🩺 As a platform visited by thousands of people across Latvia every day, Datamed is uniquely positioned to maximize the impact of these resources. Through this newly launched partnership, we will soon be bringing three of their personalized assessment tools directly into the Datamed portal: • Cervical Cancer Risk Awareness Test • Breast Cancer Risk Assessment Test • Your Menopause Guide By adding these tests to a digital space people already know and use, we will be making health screenings a lot more accessible. Once live, any female user on our portal will be able to easily complete the assessments and get practical, tailored recommendations for their daily health routine. Healthcare works best when ecosystems are open, and platforms collaborate. Together with Longenesis, we are excited to turn screening statistics into real, actionable steps for a healthier society in the near future. 🌐 #HealthTech #DigitalHealth #WomensHealth #PreventativeMedicine #Datamed #Longenesis #Partnership

    • No alternative text description for this image
  • Yesterday, we hosted our annual gathering of strategic digital health partners at the Longenesis office — this year we focused on the role of digital tools in cancer prevention, with a particular look at cervical, breast, and ovarian cancer screening. Our Life Sciences Partnerships Manager Dārta Maija Zaķe shared insights from ou Skrinings.lv platform on how digital engagement can strengthen cervical cancer prevention in Latvia — including a presentation of research into Latvian women's prevention habits, knowledge, and attitudes. Emīls Sjundjukovs spoke more broadly about our work supporting patient journeys in oncology, with a focus on a few new collaborations and scientific milestones we'll be sharing soon. Some key takeaways from the evening: 📬 A state invitation increases screening participation more than 10x 💉 Women are willing to get the HPV vaccine 🧠 Correcting myths matters as much as sharing information 🩺 The doctor remains the most trusted source of vaccination information Grateful to everyone who joined us and our partners in making the cervical cancer risk awareness test happen MSD Baltics!

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • Understanding your patients shouldn't take longer than treating them. Longenesis.Engage now generates AI summaries of patient-reported data so that clinicians can move from information to decision in less time. Whether patients submit symptom diaries, pre-visit questionnaires, or follow-up responses, Engage now condenses what matters into a single clear overview. Full responses remain available for deeper review whenever needed. 🔷 Faster patient understanding — Key details from structured answers and free-text responses surface in one concise summary. 🔷 Better-prepared consultations — Review changes in a patient's condition and critical indicators before they walk into the room. 🔷 Depth when you need it, speed when you don't — The full patient response is always one click away; the AI summary just gets you to the right starting point sooner. Built for clinicians who want more time with patients and less time parsing data.

    • No alternative text description for this image
  • Longenesis reposted this

    Yesterday in Riga, Arnolds Bogdanovs and I joined the TOGAS Closing Consortium Meeting hosted by University of Latvia Institute of Clinical and Preventive Medicine to be a part of a milestone moment for gastric cancer screening in Europe, and ultimately for the patients whose outcomes this work will reach. For Longenesis, the TOGAS EU project is more than a research collaboration. We're proud to contribute to what we see as one of the most consequential layers of the project: a unified data encoding and federated use standard for oncology in Europe. Pilot results on H. pylori screen-and-treat, health economics modelling, and policymaker attitudes all matter, and to scale across member states, an interoperable, compliant data infrastructure is needed. That's where our work sits. Grateful to be a part of this initiative with partners from across Europe! P.S. A very happy birthday to Arnolds today 🎂 — couldn't have picked a better colleague to mark this milestone with. P.P.S. Fun discovery: the back of my name tag turned out to be a lunch voucher. More than one person genuinely asked if "Lunch" was my surname. :D #TOGAS #GastricCancer #CancerScreening #EU4Health #EuropeanResearch #PublicHealth #FederatedData #HealthDataSpace

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • Onboarding new patients into a care program shouldn't take more time than the care itself! Longenesis.Engage now gives care teams a single place to manage everyone in their program — from registering new patients to tracking who's already active. Less switching between tools, less manual follow-up, more time for what matters. What this means in practice: 🔷 All participant information in one view — register new patients and manage existing ones from the same place. 🔷 Assign the right specialist at the point of registration, so patients connect with their care team from day one. 🔷 Send a simple invite link when that's all you need — no bulk imports, no setup, just share and go. 🔷 Patients choose how they sign in — eParaksts, Google, or any email — removing a common barrier to onboarding. 🔷 Track invitation status and resend with one click when a patient hasn't responded yet. For care coordinators managing chronic disease programs, post-discharge cohorts, or research participants, this means fewer patients lost between the invitation and the first interaction. Let's connect to see how Engage can support your patient onboarding!

    • No alternative text description for this image
  • Longenesis reposted this

    After today's meetings (it is always a great pleasure to meet you, Sweta Ghelani, and discuss how the New Nordics grow in terms of health innovations!), I had a chance to visit the Novartis Pavilion — a museum that walks you through the journey of designing therapies and bringing life-saving medicines to the patients who need them. The exhibition spans the full arc, from the history of pharma to its future: including AI (where I still believe Europe should lean far more into the enormous opportunity it represents), and gene editing toward longer, healthier lives, featuring voices like Prof. George Church of Harvard (we had the pleasure of working together during Nebula Genomics and Longenesis) along the way. It's the kind of place I wish existed more often. We need more galleries, more exhibitions, more media that translate the science behind our daily lives into stories people can actually feel. Drug discovery isn't abstract; it ends in someone's hospital room, in someone's family. The visit was also a quiet reminder of how fragile our lives are. What stayed with me even after leaving Basel was a book I came across in the gift shop: "Mom's Cancer" by Brian Fies. A graphic memoir about the author's mother being diagnosed with lung cancer, and the weight that illness places not only on the patient, but on the people who love them. The burden carried by family and loved ones is something we too often leave unspoken. And such silence isn't kind. Talking about it openly is how we build awareness, slowly chip away at the stigma, and support the patients and their loved ones.

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
      +1
  • Meet Emīls Sjundjukovs at the Swiss Biotech Association Swiss Biotech Days 2026!

    After 8 years, I will be back in Basel, attending the Swiss Biotech Association Swiss Biotech Day 2026. Looking forward to reconnecting with old friends and sharing what we've delivered for global Life Science players over the years — across 10+ therapeutic areas and 1.3 million patients to date. And always excited to put my rusty German in place. :) -------------------------- Nach 8 Jahren kehre ich nach Basel zurück — zum Swiss Biotech Day 2026 der Swiss Biotech Association. Ich freue mich darauf, alte Weggefährten wiederzusehen und darüber zu sprechen, welchen Mehrwert wir über die Jahre für globale Life-Science Gesseschafte, in über 10 Therapiegebieten und bislang für 1,3 Millionen Patienten geschaffen haben. #HealthAI #DigitalHealth #ClinicalResearch #PatientData #DataSovereignty

    • No alternative text description for this image

Similar pages

Browse jobs